Effect of Idelalisib on PKC beta/NF-kappa B regulation in stromal cells of chronic lymphocytic leukemia

Lutzny-Geier G, Handl SA, Von Heydebrand F, Wilke J, Kremer AL, Mackensen A, Völkl S (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 115-115

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Gloria Lutzny-Geier Department of Medicine 5 – Haematology and Oncology Sarah Annika Handl Lehrstuhl für Innere Medizin V Anna-Lena Kremer Professur für Psychosomatik und Psychotherapie Andreas Mackensen Lehrstuhl für Innere Medizin V Simon Völkl Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Lutzny-Geier, G., Handl, S.A., Von Heydebrand, F., Wilke, J., Kremer, A.-L., Mackensen, A., & Völkl, S. (2021). Effect of Idelalisib on PKC beta/NF-kappa B regulation in stromal cells of chronic lymphocytic leukemia. In ONCOLOGY RESEARCH AND TREATMENT (pp. 115-115). BASEL: KARGER.

MLA:

Lutzny-Geier, Gloria, et al. "Effect of Idelalisib on PKC beta/NF-kappa B regulation in stromal cells of chronic lymphocytic leukemia." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2021. 115-115.

BibTeX: Download